MedAdvisor (ASX:MDR) has entered into a binding agreement to sell its Australia-New Zealand business and associated intellectual property to Jonas Software AUS, for around AU$42.4 million, according to a Wednesday filing with the Australian bourse.
The deal includes a headline price of AU$35 million, with an uncapped three-year earn-out currently estimated at AU$7.4 million. A total of AU$8 million will be held back for post-completion adjustments, the filing said.
The sale, expected to close on July 8, will see MedAdvisor's US business continue under the name "MedAdvisor Solutions" via a royalty-free license, while the company will seek shareholder approval to change its name at the annual general meeting.
Shares of the company fell 2% in recent Wednesday trade.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。